Novo Nordisk
NVO
#103
Rank
HK$1.308 T
Marketcap
HK$293.56
Share price
-2.55%
Change (1 day)
-52.59%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): HK$161.12 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are HK$47.70 Billion. , an increase over its 2024 earnings that were of HK$148.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 HK$161.89 B9.13%
2024 HK$148.35 B22.84%
2023 HK$120.76 B57.81%
2022 HK$76.52 B5.24%
2021 HK$72.72 B12.38%
2020 HK$64.70 B13.11%
2019 HK$57.20 B-3.45%
2018 HK$59.25 B1.88%
2017 HK$58.15 B4.3%
2016 HK$55.75 B10.32%
2015 HK$50.54 B7.47%
2014 HK$47.03 B3.4%
2013 HK$45.48 B19.09%
2012 HK$38.19 B15.58%
2011 HK$33.04 B16.58%
2010 HK$28.34 B25.66%
2009 HK$22.55 B10.68%
2008 HK$20.38 B55.82%
2007 HK$13.08 B7.02%
2006 HK$12.22 B19.05%
2005 HK$10.26 B10.55%
2004 HK$9.28 B
2002 HK$6.53 B-14.39%
2001 HK$7.62 B-52.82%
2000 HK$16.16 B250%
1999 HK$4.61 B31.21%
1998 HK$3.51 B34.31%
1997 HK$2.62 B11.46%
1996 HK$2.35 B9.03%
1995 HK$2.15 B-3.15%
1994 HK$2.22 B-0.67%
1993 HK$2.24 B45.38%
1992 HK$1.54 B-13.81%
1991 HK$1.78 B37.12%
1990 HK$1.30 B-0.79%
1989 HK$1.31 B26.2%
1988 HK$1.04 B24.97%
1987 HK$0.83 B-0.9%
1986 HK$0.84 B-7.78%
1985 HK$0.91 B24.87%
1984 HK$0.73 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$92.90 B-42.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$176.39 B 8.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$71.33 B-55.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$62.96 B-61.11%๐Ÿ‡บ๐Ÿ‡ธ USA